Cost-effectiveness analysis of intranasal live attenuated vaccine (LAIV) versus injectable inactivated influenza vaccine (TIV) for Canadian children and adolescents

BACKGROUND: Influenza affects all age groups and is common in children. Between 15% and 42% of preschool- and school-aged children experience influenza each season. Recently, intranasal live attenuated influenza vaccine, trivalent (LAIV) has been approved in Canada. OBJECTIVE: The objective of this...

Descripción completa

Detalles Bibliográficos
Autores principales: Tarride, Jean-Eric, Burke, Natasha, Von Keyserlingk, Camilla, O’Reilly, Daria, Xie, Feng, Goeree, Ron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3468276/
https://www.ncbi.nlm.nih.gov/pubmed/23055756
http://dx.doi.org/10.2147/CEOR.S33444

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3468276/
https://www.ncbi.nlm.nih.gov/pubmed/23055756
http://dx.doi.org/10.2147/CEOR.S33444

Ejemplares similares